Armata Pharmaceuticals Statistics
Share Statistics
Armata Pharmaceuticals has 36.19M
shares outstanding. The number of shares has increased by 0.08%
in one year.
| Shares Outstanding | 36.19M |
| Shares Change (YoY) | 0.08% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 3.84% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 230 |
| FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 4.18K, so 0.01% of the outstanding
shares have been sold short.
| Short Interest | 4.18K |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -3.54 and the forward
PE ratio is -2.61.
Armata Pharmaceuticals's PEG ratio is
0.05.
| PE Ratio | -3.54 |
| Forward PE | -2.61 |
| PS Ratio | 12.93 |
| Forward PS | 1.3 |
| PB Ratio | -1.39 |
| P/FCF Ratio | -1.7 |
| PEG Ratio | 0.05 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Armata Pharmaceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.23,
with a Debt / Equity ratio of -2.63.
| Current Ratio | 0.23 |
| Quick Ratio | 0.23 |
| Debt / Equity | -2.63 |
| Debt / EBITDA | -18.47 |
| Debt / FCF | -3.21 |
| Interest Coverage | -3.95 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $86,233.33 |
| Profits Per Employee | $-315,266.67 |
| Employee Count | 60 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -28.36% in the
last 52 weeks. The beta is 0.97, so Armata Pharmaceuticals's
price volatility has been higher than the market average.
| Beta | 0.97 |
| 52-Week Price Change | -28.36% |
| 50-Day Moving Average | 1.51 |
| 200-Day Moving Average | 2.02 |
| Relative Strength Index (RSI) | 56.46 |
| Average Volume (20 Days) | 245,414 |
Income Statement
In the last 12 months, Armata Pharmaceuticals had revenue of 5.17M
and earned -18.92M
in profits. Earnings per share was -0.52.
| Revenue | 5.17M |
| Gross Profit | 3.85M |
| Operating Income | -42.44M |
| Net Income | -18.92M |
| EBITDA | -6.85M |
| EBIT | -8.17M |
| Earnings Per Share (EPS) | -0.52 |
Full Income StatementBalance Sheet
The company has 9.29M in cash and 126.52M in
debt, giving a net cash position of -117.22M.
| Cash & Cash Equivalents | 9.29M |
| Total Debt | 126.52M |
| Net Cash | -117.22M |
| Retained Earnings | -327.74M |
| Total Assets | 87.25M |
| Working Capital | -97.37M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -37.55M
and capital expenditures -1.88M, giving a free cash flow of -39.43M.
| Operating Cash Flow | -37.55M |
| Capital Expenditures | -1.88M |
| Free Cash Flow | -39.43M |
| FCF Per Share | -1.09 |
Full Cash Flow StatementMargins
Gross margin is 74.39%, with operating and profit margins of -820.18% and -365.6%.
| Gross Margin | 74.39% |
| Operating Margin | -820.18% |
| Pretax Margin | -365.6% |
| Profit Margin | -365.6% |
| EBITDA Margin | -132.37% |
| EBIT Margin | -820.18% |
| FCF Margin | -762.08% |
